Skip to Content

KU 180 mg (Temozolomide 180 mg)

Pill with imprint KU 180 mg is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Kremers Urban Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 180 mg

Temozolomide 180 mg KU 180 mg

Temozolomide

Imprint
KU 180 mg
Strength
180 mg
Color
Orange & White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Kremers Urban Pharmaceuticals Inc.
National Drug Code (NDC)
62175-0244
Inactive Ingredients
lactose anhydrous, silicon dioxide, sodium starch glycolate type A potato, tartaric acid, stearic acid, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.